Agreement between different parameters of dialysis dose in achieving treatment targets: results from the NECOSAD study.

BACKGROUND The recommended parameter of dialysis dose differs between K-DOQI and the European Best Practice Guidelines. It is not well known to what extent an agreement exists between the different parameters, nor if target and delivered dialysis dose are prescribed according to the urea reduction rate (URR), single-pool Kt/V (spKt/V) or equilibrated double-pool Kt/V (eKt/V) and which parameter is most strongly related to mortality. METHODS In 830 haemodialysis patients from the NECOSAD cohort URR, spKt/V and eKt/V were calculated and compared according to a classification regarding the recommended treatment targets (70%, 1.4 and 1.2, respectively) as well as minimum delivered dialysis dose (65%, 1.2 and 1.05, respectively). Moreover, the relation between treatment dose and survival was assessed using Cox regression analysis. RESULTS A spKt/V of ≥1.4 and URR ≥70% corresponded with eKt/V ≥1.20 (as reference method) in, respectively, 98.0 and 90.6% of patients. spKt/V of ≥1.2 and URR ≥65% corresponded with eKt/V ≥1.05 in, respectively, 95.5 and 91.2% of patients. Deviations from the reference method were significantly related to differences in urea distribution volume (spKt/V), treatment time (URR) and ultrafiltration volume (URR). The adjusted HR (95% CI) was 0.98 (0.96, 0.99) for URR, 0.51 (0.31, 0.84) for spKt/V and 0.46 (0.30, 0.80) for the eKt/V. CONCLUSION The use of URR leads to larger disagreement with the reference method (eKt/V) treatment target as compared to spKt/V. Low urea distribution volume, short treatment time and low ultrafiltration volumes are predictive parameters for overestimation of dialysis dose when utilizing the alternative methods spKt/V and URR instead of eKt/V. Delivered eKt/V, spKt/V and URR were all positively related to survival.

[1]  Kimbroe J. Carter,et al.  Urea Reduction Ratio and Urea Kinetic Modeling: A Mathematical Analysis of Changing Dialysis Parameters , 1998, American Journal of Nephrology.

[2]  A. Collins,et al.  Predictors of ESA Use in the Non-Dialysis Chronic Kidney Disease Population with Anemia , 2009, Nephron Clinical Practice.

[3]  W. Owen,et al.  Exploring the reverse J-shaped curve between urea reduction ratio and mortality. , 1999, Kidney international.

[4]  I. NKF-K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy: update 2000. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  References , 1971 .

[6]  C. Wanner,et al.  EBPG guideline on dialysis strategies. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  H. Harter Review of significant findings from the National Cooperative Dialysis Study and recommendations. , 1983, Kidney international. Supplement.

[8]  John T Daugirdas,et al.  Factors that affect postdialysis rebound in serum urea concentration, including the rate of dialysis: results from the HEMO Study. , 2004, Journal of the American Society of Nephrology : JASN.

[9]  E G Lowrie,et al.  The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. , 1993, The New England journal of medicine.

[10]  I. Khan,et al.  Influence of coexisting disease on survival on renal-replacement therapy , 1993, The Lancet.

[11]  R. Cody,et al.  Accuracy of the urea reduction ratio in predicting dialysis delivery. , 1995, Kidney international.

[12]  F. Collart,et al.  Assessment of urea removal in haemodialysis and the impact of the European Best Practice Guidelines. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  G. Beck,et al.  Dialysis dose and the effect of gender and body size on outcome in the HEMO Study. , 2004, Kidney international.

[14]  E G Lowrie,et al.  The urea [clearance x dialysis time] product (Kt) as an outcome-based measure of hemodialysis dose. , 1999, Kidney international.

[15]  A. Casula,et al.  Chapter 8: Adequacy of Haemodialysis in UK Renal Centres in 2008: national and centre-specific analyses , 2010, Nephron Clinical Practice.

[16]  N. Qureshi Mortality and duration of hemodialysis treatment. , 1991, JAMA.

[17]  R. Wolfe,et al.  Clinical outcome relative to the dose of dialysis is not what you think: the fallacy of the mean. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  J. Hornberger The hemodialysis prescription and quality-adjusted life expectancy. Renal Physicians Association Working Committee on Clinical Guidelines. , 1993, Journal of the American Society of Nephrology : JASN.

[19]  I. Aoyama,et al.  An oral adsorbent ameliorates renal overload of indoxyl sulfate and progression of renal failure in diabetic rats. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  C. Tomson,et al.  UK Renal Registry 11th Annual Report (December 2008): Chapter 8 Adequacy of haemodialysis in UK renal centres in 2007: national and centre-specific analyses , 2009, Nephron Clinical Practice.

[21]  C Basile,et al.  Percent reduction in blood urea concentration during dialysis estimates Kt/V in a simple and accurate way. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  M. Kimmel,et al.  Conflict of interest statement. None declared. , 2010 .

[23]  F. Dekker,et al.  Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. , 2004, Journal of the American Society of Nephrology : JASN.

[24]  Mortality and duration of hemodialysis treatment. , 1991, JAMA.

[25]  R Cornet,et al.  Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  M. Babu Percent reduction in blood urea concentration during dialysis estimates Kt/V in a simple and accurate way. , 1990, American Journal of Kidney Diseases.

[27]  N W Levin,et al.  Design and statistical issues of the hemodialysis (HEMO) study. , 2000, Controlled clinical trials.

[28]  W. Owen,et al.  Dose of hemodialysis and survival: differences by race and sex. , 1998, JAMA.

[29]  B. Charra,et al.  Survival as an index of adequacy of dialysis. , 1992, Kidney international.